Literature DB >> 32775537

FRET Reporter Assays for cAMP and Calcium in a 96-well Format Using Genetically Encoded Biosensors Expressed in Living Cells.

Brandon T Milliken1, Robert P Doyle1,2, George G Holz2, Oleg G Chepurny2.   

Abstract

Stimulation of G protein-coupled receptors (GPCR) by hormones and neurotransmitters elicits cellular responses, many of which result from alterations in the concentrations of cytosolic cAMP and Ca2+. Here, we describe a microplate reader fluorescence resonance energy transfer (FRET) assay that uses the genetically encoded biosensors H188 and YC3.60 so that it is possible to monitor the kinetics with which alterations of [cAMP] or [Ca2+] occur in monolayers or suspensions of living cells exposed to GPCR agonists. This protocol uses HEK293 cell lines doubly transfected with a FRET biosensor and a recombinant GPCR of interest (e.g., glucagon receptors, CCK2 receptors, or NPY2R receptors). The protocol allows for rapid screening of small molecule GPCR agonists and antagonists, and it is also useful for discovery of synthetic mono-, dual-, and tri- agonist peptides with GPCR activating properties.

Entities:  

Keywords:  Ca2+; FRET; GPCR; High-throughput screening; cAMP

Year:  2020        PMID: 32775537      PMCID: PMC7409823          DOI: 10.21769/bioprotoc.3641

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  6 in total

1.  Expanded dynamic range of fluorescent indicators for Ca(2+) by circularly permuted yellow fluorescent proteins.

Authors:  Takeharu Nagai; Shuichi Yamada; Takashi Tominaga; Michinori Ichikawa; Atsushi Miyawaki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

2.  Novel single chain cAMP sensors for receptor-induced signal propagation.

Authors:  Viacheslav O Nikolaev; Moritz Bünemann; Lutz Hein; Annette Hannawacker; Martin J Lohse
Journal:  J Biol Chem       Date:  2004-07-01       Impact factor: 5.157

3.  Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.

Authors:  Oleg G Chepurny; Minos-Timotheos Matsoukas; George Liapakis; Colin A Leech; Brandon T Milliken; Robert P Doyle; George G Holz
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

4.  Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclic AMP analog in rat INS-1 cells: studies with 8-pCPT-2'-O-Me-cAMP-AM.

Authors:  Oleg G Chepurny; Colin A Leech; Grant G Kelley; Igor Dzhura; Elvira Dzhura; Xiangquan Li; Michael J Rindler; Frank Schwede; Hans G Genieser; George G Holz
Journal:  J Biol Chem       Date:  2009-02-25       Impact factor: 5.157

5.  Fourth-generation epac-based FRET sensors for cAMP feature exceptional brightness, photostability and dynamic range: characterization of dedicated sensors for FLIM, for ratiometry and with high affinity.

Authors:  Jeffrey Klarenbeek; Joachim Goedhart; Aernoud van Batenburg; Daniella Groenewald; Kees Jalink
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

6.  Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors.

Authors:  Oleg G Chepurny; Ron L Bonaccorso; Colin A Leech; Torsten Wöllert; George M Langford; Frank Schwede; Christian L Roth; Robert P Doyle; George G Holz
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

  6 in total
  3 in total

1.  Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis.

Authors:  Brandon T Milliken; Clinton Elfers; Oleg G Chepurny; Kylie S Chichura; Ian R Sweet; Tito Borner; Matthew R Hayes; Bart C De Jonghe; George G Holz; Christian L Roth; Robert P Doyle
Journal:  J Med Chem       Date:  2021-01-15       Impact factor: 7.446

2.  Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK2R Cancer Theranostic Agents: A Preclinical Study.

Authors:  Berthold A Nock; Panagiotis Kanellopoulos; Oleg G Chepurny; Maritina Rouchota; George Loudos; George G Holz; Eric P Krenning; Theodosia Maina
Journal:  Pharmaceutics       Date:  2022-03-18       Impact factor: 6.321

3.  Synthesis, in vitro biological investigation, and molecular dynamics simulations of thiazolopyrimidine based compounds as corticotrophin releasing factor receptor-1 antagonists.

Authors:  Hossam R Elgiushy; Nageh A Abou-Taleb; George G Holz; Oleg G Chepurny; Ioannis Pirmettis; Sotirios Kakabakos; Vlasios Karageorgos; George Liapakis; Amgad Albohy; Khaled A M Abouzid; Sherif F Hammad
Journal:  Bioorg Chem       Date:  2021-06-10       Impact factor: 5.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.